CAR-based adoptive cell therapy (ACT) has shown a remarkable ability to treat and occasionally cure cancer by evoking or grafting an anti-cancer immune response into patients with hematological malignancies but has yet to show similar efficacy in solid tumors. In...
CEO/CSO Geir Åge Løset and Head of Business Development Francis Yuan will attend the BIO Europe 2023 in Munich, Germany, November 6 – 8. We are interested in discussing partnerships, collaborations, and asset out-licensing - please get in touch if you would like...
Nextera’s CEO, Geir Åge Løset will give the presentation ” Combinatorial specificity profiling and engineering to safeguard and optimize TCR reactivity”
At the 12th annual PEGS Europe Summit, Nextera’s CEO GeirÅge Løset will present Nextera’s NextCore drug discovery platform.
This conference is the industry’s event for antibody and protein therapeutic science and technology in Europe. Nextera is in the forefront of such technology development.
CEO Geir Åge Løset and CBO Ole Henrik Brekke will attend the BIO International Convention June 8th – 12th. Book us for a digital meeting and we will present our unique NextCore Immunology platform.
CEO Geir Åge Løset and CBO Ole Henrik Brekke will attend the BIO Europe Spring Digital conference March 23rd – 25th.